Wednesday, 18 November 2026LatestVideosAboutContact
Latest
Cricket Australia will not re-open Sandpaper-gate investigation, but sets up independent commission for tour membersTelangana High Court directs safeguards in placement of rescued women in Protective HomesFlat opening as Nvidia earnings beat softens Wall Street’s blow; Bank Nifty holds near record highMultiple tech systems have been crashing. Here is how to protect yourselfSandpapergate: Cricket Australia ready to hear all sides, but won't probe againMicrosoft takes on OpenAI and Anthropic with new coding AI modelTelangana High Court issues notices over alleged illegal Task Force searchesHaaland's late penalty sends Norway into Nations League quarters, Portugal top groupBeware the Basin bluff! Gill's four-pacer plan looks beyond the first morningP.V. Sindhu returns to world top five after four years; Lakshya Sen closes in on top 10Biocon's Pebrilzo gets EU nod for HER2-positive breast cancer treatmentPakistan Players Show Respect To Team India With Special Guard Of Honour After SAFF Championship Final Triumph | Video
BusinessUpdated 20 min ago

Biocon's Pebrilzo gets EU nod for HER2-positive breast cancer treatment

Image: Business Standard

The approval makes Biocon's pertuzumab the first biosimilar to receive EC marketing authorisation under the European Medicines Agency's (EMA) new tailored clinical approach

Continue reading on Business Standard

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all